Ditchcarbon
  • Contact
  1. Organizations
  2. A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung
Public Profile
Pharmaceutical Preparation Manufacturing
DE
updated 3 months ago

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung Sustainability Profile

Company website

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung, commonly referred to as Nattermann, is a distinguished player in the pharmaceutical and biotechnology industry, headquartered in Germany. Founded in the early 20th century, the company has established a strong presence in Europe and beyond, focusing on the development and production of high-quality active pharmaceutical ingredients (APIs) and intermediates. Nattermann is renowned for its commitment to innovation and quality, offering a diverse range of products that cater to various therapeutic areas. The company has achieved significant milestones, including strategic partnerships and expansions that have solidified its market position. With a reputation for excellence, A. Nattermann & Cie. continues to contribute to advancements in healthcare, making it a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's reported carbon emissions

Inherited from Sanofi

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung currently does not report any specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of Sanofi, which influences its climate commitments and initiatives. While A. Nattermann & Cie. does not have its own reduction targets or climate pledges, it inherits sustainability initiatives from its parent company, Sanofi. This includes participation in various climate-related frameworks such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded down from Sanofi. As part of its corporate family, A. Nattermann & Cie. aligns with Sanofi's broader climate strategy, which aims to reduce emissions across all scopes, although specific targets for A. Nattermann & Cie. have not been detailed. The company is expected to contribute to the overarching goals set by Sanofi, focusing on sustainable practices and emissions reduction in the pharmaceutical industry. In summary, while A. Nattermann & Cie. does not have specific emissions data or reduction targets, it is positioned within a framework of climate commitments inherited from Sanofi, reflecting a commitment to sustainability in its operations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20102011201220132015201920202021202220232024
Scope 1
545,114,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
677,549,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
-
-
-
0,000,000,000
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung is in DE, which has a medium grid carbon intensity relative to other regions.

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's Scope 3 Categories Breakdown

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's Scope 3 emissions, which decreased by 5% last year and increased by approximately 40% since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 69% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
69%
End-of-Life Treatment of Sold Products
5%
Capital Goods
5%
Business Travel
4%
Upstream Transportation & Distribution
4%
Waste Generated in Operations
3%
Fuel and Energy Related Activities
3%
Employee Commuting
3%
Use of Sold Products
2%
Investments
<1%

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare A. Nattermann & Cie. Gesellschaft Mit Beschränkter Haftung's Emissions with Industry Peers

Vifor (International) AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Shield Therapeutics plc

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

AMAG Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Rockwell Medical, Inc.

US
•
Health and social work services (85)
Updated 26 days ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy